J&J To Deliver Up To 400 Million COVID-19 Vaccines To Africa
Up to 400 million doses of Johnson & Johnson’s Covid-19 vaccine will be made available to African countries, the US pharmaceutical giant said Monday. The availability of the single-shot vaccine…
Global Trial Shows Johnson & Johnson’s Single-Shot Vaccine Is 66% Effective
Johnson & Johnson’s single-shot Covid-19 vaccine has an overall efficacy of 66 percent, the company announced Friday, following results from a phase 3 trial of almost 44,000 people across many…
COVID-19: Pfizer-BioNTech vaccine deliveries could begin Dec.
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no…
J&J begins two-dose trial of its COVID-19 vaccine candidate
Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of…
South Africa’s Aspen agrees initial deal to make J&J vaccine candidate
South African pharmaceutical company Aspen Pharmacare said on Monday it had reached a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher….